Укр
Eng
SAFE, AFFORDABLE, AND EFFECTIVE MEDICINES FOR UKRAINIANS (SAFEMed) ACTIVITY
MONTHLY NEWS DIGEST NOVEMBER 2023
On October 17, the MOH approved legislation, drafted with support from SAFEMed partner Legal Alliance, requiring the international non-proprietary name (INN) of medicines to be indicated on paper and electronic prescriptions along with the mandatory indication of the form and dosage.This change is designed to expand use of generic medicines that are of equal quality but lower cost, thus increasing access and affordability of medicines for the Ukrainian population. Order No. 1806 amends the Rules for Prescribing Medicinal Products and Medical Devices, which has been in place since 2005, and states that, at the start of the new year, both paper and ePrescriptions will be issued under the trade name of the medicinal product only in the following cases:
These changes come after the Antimonopoly Committee of Ukraine recommended strengthening the requirements regarding the possibility for health care professionals to indicate the trade names of medicinal products in prescriptions, taking into account international experience. Also, according to the amendments, ePrescriptions for products providing reimbursed palliative care are issued by family doctors for all patients, except those with mental and behavioral disorders. For individuals with mental and behavioral disorders, ePrescriptions for these specified products are exclusively issued by doctors specializing in psychiatry, child psychiatry, and narcology.
We are thrilled to announce a major milestone in our team's growth and celebrate the well-deserved career advancements of our colleagues.
Lexology Index: Employment & Labor highlights the leading legal specialists in the field from around the world.
On June 19, 2026, an event was held with the participation of businesses, regulators, and experts – titled “Regulatory Dialogue: The Cosmetics Market” – organiz
The event brought together leading industry experts for a comprehensive analysis of the institutional landscape and current legal challenges in the sphere of state-business interaction.
